Ono-8539

Ono-8539

SCHEMBL29572731

Cc1cc(C(=O)O)ccc1COc1cc2c(cc1N(CC(C)C)S(=O)(=O)c1nccs1)CCC2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PTGER1

The experimentally established mechanism targets of Ono-8539. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 2/20 0.33
TRPM8 Q7Z2W7 3/20 0.33
EP300 Q09472 1/20 0.33
NLRP3 Q96P20 1/20 0.33
KDM5A P29375 1/20 0.33
KDM4C Q9H3R0 1/20 0.33
KDM5B Q9UGL1 1/20 0.33
RXRA P19793 2/20 0.32
RXRB P28702 2/20 0.32
MRGPRX4 Q96LA9 1/20 0.32
NPC1 O15118 1/20 0.32
RXRG P48443 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ono-8539 SCHEMBL214853 1.00 MCL1 (0.33) MCL1TRPM8EP300NLRP3KDM5A
SCHEMBL15456470 0.92 NLRP3 (0.34) EP300NLRP3NPC1RAB9A
SCHEMBL215320 0.90 MCL1 (0.36) MCL1EP300KDM5AKDM4CKDM5B
SCHEMBL213550 0.90 NLRP3 (0.34) TRPM8NLRP3KDM5AKDM4CKDM5B
SCHEMBL214578 0.90 MCL1 (0.35) MCL1EP300KDM5AKDM4CKDM5B
SCHEMBL215919 0.89 RXRB (0.44) TRPM8EP300RXRARXRBNPC1
SCHEMBL213408 0.88 MCL1 (0.34) MCL1TRPM8RXRARXRBMRGPRX4
SCHEMBL214486 0.87 RECQL (0.35) EP300RAB9A
SCHEMBL214485 0.87 RECQL (0.35) EP300RAB9A
SCHEMBL212682 0.84 MCL1 (0.35) MCL1RXRARXRBMRGPRX4NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3686188-B1 PYRAZOLE DERIVATIVE, OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF KISSEI PHARMACEUTICAL (JP) 2022-04-06 EP disclosed